Fellowship · Indianapolis, IN
Sponsored by Indiana University School of Medicine
A multisociety Delphi consensus statement on new fatty liver disease nomenclature.
Journal of hepatology · 2023 · 2,696 citations · Samer Gawrieh
A multisociety Delphi consensus statement on new fatty liver disease nomenclature.
Hepatology (Baltimore, Md.) · 2023 · 2,397 citations · Samer Gawrieh
Tirzepatide for Metabolic Dysfunction-Associated Steatohepatitis with Liver Fibrosis.
The New England journal of medicine · 2024 · 761 citations · Raj Vuppalanchi
A multisociety Delphi consensus statement on new fatty liver disease nomenclature.
Annals of hepatology · 2024 · 542 citations · Samer Gawrieh
Prospective Study of Outcomes in Adults with Nonalcoholic Fatty Liver Disease.
The New England journal of medicine · 2021 · 954 citations · Naga Chalasani
Metabolic dysfunction and alcohol-related liver disease (MetALD): Position statement by an expert panel on alcohol-related liver disease.
Journal of hepatology · 2025 · 148 citations · Suthat Liangpunsakul
Efruxifermin in Compensated Liver Cirrhosis Caused by MASH.
The New England journal of medicine · 2025 · 102 citations · Naga Chalasani
Health disparities in chronic liver disease.
Hepatology (Baltimore, Md.) · 2023 · 203 citations · Lauren Nephew